Rotary to organise CPR camps, health checkups for frontline cops
Throwing light on the toll law enforcement officers paid during the stampede, ADGP KV Sharath Chandra said, 'Our men and women in uniform need to be trained not just in riot control but in reviving a life. CPR is useful for both police and people.'
Now, with heart attacks increasing among people in their 20s and 30s, CPR literacy has become essential.
Rotary Bangalore Northwest has pledged to organize CPR training and health checkups for frontline police, especially armed and civil forces deployed on high-stress bandobast duty. Former police commissioner Bhaskar Rao, advising the public to step up during medical emergencies, said, 'Every second counts. You don't need a uniform to save a life, just training and courage.'
Lakshmi Achuta, president of Rotary Bangalore Northwest and Principal Strategic Adviser, Biotech, at Biocon, said it is not enough to train only the police. 'Imagine how many lives could have been saved at the KSCA stampede if more people in the crowd knew CPR. It is about empowering everyone with a life-saving skill.'
The movement has also gone global. Rajiv Thalla, based in the United States, has turned a personal heartbreak into a mission. After losing his 23-year-old son Rohan Rajiv to a sudden heart attack, he has taken it on himself to hold free CPR demonstrations, to ensure others don't suffer the same fate. He travels across cities, from Los Angeles to Lucknow, distributing educational material, and partnering with Rotary.
His younger son, a doctor, stands by him. 'This isn't just about first aid, but first response. A few minutes can mean the difference between life and death. CPR gives you those minutes.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
3 days ago
- New Indian Express
Rotary to organise CPR camps, health checkups for frontline cops
BENGALURU: The June 4 stampede at Chinnaswamy Stadium that claimed 11 lives and left several police personnel injured, has shaken up Karnataka. There is a call by senior officers and civic leaders to train police and citizens in the skill of cardiopulmonary resuscitation (CPR). Throwing light on the toll law enforcement officers paid during the stampede, ADGP KV Sharath Chandra said, 'Our men and women in uniform need to be trained not just in riot control but in reviving a life. CPR is useful for both police and people.' Now, with heart attacks increasing among people in their 20s and 30s, CPR literacy has become essential. Rotary Bangalore Northwest has pledged to organize CPR training and health checkups for frontline police, especially armed and civil forces deployed on high-stress bandobast duty. Former police commissioner Bhaskar Rao, advising the public to step up during medical emergencies, said, 'Every second counts. You don't need a uniform to save a life, just training and courage.' Lakshmi Achuta, president of Rotary Bangalore Northwest and Principal Strategic Adviser, Biotech, at Biocon, said it is not enough to train only the police. 'Imagine how many lives could have been saved at the KSCA stampede if more people in the crowd knew CPR. It is about empowering everyone with a life-saving skill.' The movement has also gone global. Rajiv Thalla, based in the United States, has turned a personal heartbreak into a mission. After losing his 23-year-old son Rohan Rajiv to a sudden heart attack, he has taken it on himself to hold free CPR demonstrations, to ensure others don't suffer the same fate. He travels across cities, from Los Angeles to Lucknow, distributing educational material, and partnering with Rotary. His younger son, a doctor, stands by him. 'This isn't just about first aid, but first response. A few minutes can mean the difference between life and death. CPR gives you those minutes.'
Economic Times
6 days ago
- Economic Times
Biocon Biologics launches product for autoimmune diseases in Australia
Biocon on Wednesday said its subsidiary Biocon Biologics has launched a product for the treatment of autoimmune diseases like rheumatoid arthritis, in the Australian market. The company has launched Nepexto, a biosimilar to the reference product Enbrel (Etanercept), in Australia, the company said in a regulatory filing. Nepexto will be promoted by Generic Health, a local partner and a leading provider of high-quality generic prescription, injectable and over-the-counter medicines, to expand access to patients in that country, it added. Etanercept is a fusion-protein that inhibits tumour necrosis factor (TNF) and is used in the treatment of autoimmune diseases like rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Since receiving EU marketing authorisation in 2020, Nepexto has earned broad adoption across Europe. Following the 2022 acquisition and vertical integration of the biosimilars business globally, Biocon Biologics is building on the solid foundation to strategically expand Nepexto into new markets worldwide and further strengthen its immunology offering, it said. Shares of Biocon were trading 1.72 per cent up at Rs 393.70 apiece on BSE.
Business Standard
6 days ago
- Business Standard
Biocon Biologics launches biosimilar
Biocon Biologics (BBL), a fully integrated global biosimilars company and subsidiary of Biocon, announced today it has launched Nepexto, a biosimilar to the reference product Enbrel (Etanercept), in Australia. Nepexto will be promoted by Generic Health, its local partner and a leading provider of high-quality generic prescription, injectable and over-the counter medicines, to expand access to patients in Australia. Etanercept is a fusion-protein that inhibits tumor necrosis factor (TNF) and is used in the treatment of autoimmune diseases like rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Since receiving EU marketing authorization in 2020, Nepexto has earned broad adoption across Europe. Following the 2022 acquisition and vertical integration of the biosimilars business globally, Biocon Biologics is building on the solid foundation to strategically expand Nepexto into new markets worldwide and further strengthen the company's immunology offering.
